Conversations from Our Public Company Virtual Situation Room, Episode 3
In this episode, the Fenwick team addresses complex issues facing public company boards and compensation committees as companies adapt to the economic impact of COVID-19, as well as considerations for executive compensation actions, including timing, adjustments of performance targets, exercise of discretion, usage of equity, repricings, expiring equity awards, salary adjustments and related matters.
Go directly to the topic(s) of most interest to you:
Big picture – 1:36
Go forward performance metrics and adjusting existing metrics
– 4:45
Executive salary reductions – 10:01
Re-pricing – 17:32
Expiring equity grants – 19:00
409A considerations – 20:51
Fenwick's periodic videocasts discuss key topics that you, your company, board, board committees, and public reporting and compliance teams need to focus on during the COVID-19 pandemic. The Fenwick team will share best practices and steps that we are seeing our tech and life sciences clients take during these uncertain times.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
